Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.
What is the forecasted revenue size of the optical genome mapping industry by 2029?
The optical genome mapping market size has grown exponentially in recent years. It will grow from $0.17 billion in 2024 to $0.23 billion in 2025 at a compound annual growth rate (CAGR) of 29.7%. The growth in the historic period can be attributed to increasing demand for advanced genomic analysis tools and techniques, increasing research on large-scale genome identification, increasing number of collaborations between instrument manufacturers and hospitals, adoption of optical genome mapping in research institutions and pharmaceutical companies and cost-effectiveness and efficiency lead to rapid analysis of large genomes with high accuracy.
The optical genome mapping market size is expected to see exponential growth in the next few years. It will grow to $0.63 billion in 2029 at a compound annual growth rate (CAGR) of 29.4%. The growth in the forecast period can be attributed to advancements in genomic research, increasing demand for precision medicine, rising government funding and initiatives, robust healthcare infrastructure, and increasing prevalence of genetic diseases and cancer. Major trends in the forecast period include advanced OGM services, genomic research initiatives, advancements in DNA mapping technologies, technological advancements, and advancements in data analysis technologies such as AI and ML for genomic data processing.
Download Your Free Sample PDF:
Which industry-specific innovations are acting as key drivers for the optical genome mapping market?
The increasing demand for precision medicine is expected to propel the growth of the optical genome mapping market going forward. Precision medicine is an approach to healthcare that customizes medical treatment and prevention strategies to individual characteristics such as genetic makeup, lifestyle, and environment. Precision medicine demand is driven by the rising prevalence of chronic diseases, advancements in genomic technologies, increasing investment and funding, and patient demand for personalized care. optical genome mapping enhances the capabilities of precision medicine by providing a detailed and accurate understanding of the genomic alterations associated with various diseases. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the increasing demand for precision medicine is driving the growth of the optical genome mapping market.
Which segment currently leads the optical genome mapping market in terms of revenue share?
The optical genome mapping market covered in this report is segmented –
1) By Product: Instruments, Consumables And Reagents, Software, Services
2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications
3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices
2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells
3) By Software: Data Analysis Software, Image Processing Software, Mapping Software
4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services
View The Full Market Report:
How are emerging trends transforming the optical genome mapping market dynamics?
Major companies operating in the optical genome mapping market are developing optical genome mapping-based laboratory-developed tests (LDT) to enhance diagnostic capabilities and offer more accurate genomic insights. Optical genome mapping-based laboratory-developed tests (LDTs) are diagnostic assays designed and implemented within individual clinical laboratories using optical genome mapping (OGM) technology. For instance, in September 2022, Bionano Genomics Inc., a US-based company providing genome analysis software, launched optical genome mapping-based LDT for facioscapulohumeral muscular dystrophy (FSHD). The OGM-based LDT will enable Bionano Laboratories to offer services to customers seeking to implement OGM into their diagnostic routines and for research applications with hospitals, pharmaceutical companies, and other parties.
Who are the top competitors in the global optical genome mapping market?
Major companies operating in the optical genome mapping market are Agilent Technologies Inc., Illumina Inc., PerkinElmer Genomics, Bio-Rad Laboratories Inc., Qiagen N.V., Cerba Healthcare, GenScript Biotech Corporation, 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., NanoString Technologies Inc., MedGenome, Element Biosciences, Bionano Genomics Inc., Stratos Genomics, BioSkryb Genomics, Source Genomics, Genoox, Nucleome Informatics Private Limited, Praxis Genomics LLC, Phase Genomics Inc., Daicel Arbor Biosciences, Nabsys, OpGen, Genohub Inc.
What regional dynamics are shaping the future of the global optical genome mapping market?
North America was the largest region in the optical genome mapping market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Optical Genome Mapping Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Optical Genome Mapping Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment